Skip to search formSkip to main contentSkip to account menu

Puregon

National Institutes of Health

Related topics

Related topics

2 relations
Follistim

Broader (1)

follitropin beta

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Evaluation of the use and handling of three different pen systems considered for in vitro fertilization treatment
Objective: The objective of this study was to assess and compare the features of the Bemfola, Gonal-f and Puregon injection pens… 
Review
2011
Review
2011
The effects of acupuncture on in vitro fertilization outcomes: a systematic review of the literature and an update to the Cochrane Collaboration review
Background Infertility, or impaired fecundity, affects 11.8% of women between the ages of 15 and 44, which translates to 7.3… 
2011
2011
Effects of α and β recombinant FSH (Gonal-F, Puregon) and progesterone upon human endometrial cell proliferation in-vitro: a preliminary study
Endometrial proliferation or regeneration during menstrual cycle is regulated by sexual hormones. However, the effect of… 
Review
2010
Review
2010
Unilateral ovarian endometriotic cysts do not impair follicles development, oocyte and embryo quality: report on eight controlled ovarian hyperstimulations and ICSI cycles.
Sir, We thank Benaglia et al. (2009) for their interesting study. In contrast to Nakagawa et al. (2008), they found that… 
2006
2006
P-306 Delayed timing of human chorionic gonadotropin injection in combination with earlier insemination can improve the outcome of intrauterine insemination
Introduction: Different protocols are used in intrauterine insemination (IUI) to improve the successful rate, but the results and… 
2003
2003
Ovulation induction with a starting dose of 50 IU of recombinant follicle stimulating hormone in WHO group II anovulatory women: the IO‐50 study, a prospective, observational, multicentre, open trial
Objective To assess the efficacy and safety in clinical practice of a low dose regimen of 50 IU of recombinant follicle… 
Review
2003
Review
2003
Assisted conception. I—General principles
Although many assisted conception technologies exist—and have a bewildering array of acronyms—their principal aim is similar… 
Review
1999
Review
1999
What are the clinical benefits of recombinant gonadotrophins? Is Puregon a 'good' or'super' drug?
There is still a paucity of published real-life clinical experience with the use of first generation recombinant follicle… 
1996
1996
Internal carbohydrate complexity of the oligosaccharide chains of recombinant human follicle stimulating hormone (Puregon, Org 32489): a comparison with Metrodin and Metrodin-HP.
Glycoforms of recombinant human follicle stimulating hormone (rhFSH) (Org 32489, Puregon) were characterized using concanavalin A… 
1996
1996
Oestradiol and immunoreactive inhibin-like secretory patterns following controlled ovarian hyperstimulation with urinary (Metrodin) or recombinant follicle stimulating hormone (Puregon).
Inhibin (and its alpha-subunit) may be of particular value as a marker for follicular development in in-vitro fertilization (IVF… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)